Aminoimidazoquinoline derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/211, 260/246

C07D 471/04 (2006.01) A61K 31/47 (2006.01) A61K 31/535 (2006.01)

Patent

CA 1309095

ABSTRACT Novel series of 2,3-dihydro-2-oxo-1H-imidazo- [4,5-b]quinolinyl amine derivatives of Formula Image wherein R1 is hydrogen, lower alkyl; R2 is hydrogen, lower alkyl, lower alkoxy, halogen; R3 is hydrogen, lower alkyl, R4 is hydrogen, lower alkyl, alkanoyl, phenylalkanoyl wherein phenyl is optionally substituted with halogen, lower alkyl, or lower alkoxy; R3 and R4 are joined together to form morpholinyl, piperidinyl or pyrrolidinyl optionally substituted with -CO2R5 or -?NR5R6 wherein R5 is wherein R5 is hydrogen or lower alkyl, and R6 is hydrogen, lower alkyl, cycloalkyl; 4-R7-piperazinyl wherein R7 is -CO2R8 wherein R8 is lower alkyl, phenyl optionally substituted with up to 2 halogen, lower alkyl or lower alkoxy; phenylalkanoyl of 7 to 10 carbon wherein phenyl is unsubstituted or independently substituted with up to 2 halogen, lower alkyl, lower alkoxy. The compounds are cyclic AMP phosphodiesterase inhibitors and are particularly useful as inhibitors of blood platelet aggregation and/or as cardiotonic agents.

541538

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aminoimidazoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminoimidazoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminoimidazoquinoline derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1245122

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.